$0.097
-0.000 (-0.21%)Al cierre
- High
- 0.097
- Open
- 0.092
- VWAP
- 0.10
- Vol
- 790.94K
- Mkt Cap
- 149.83M
- Low
- 0.092
- Amount
- 75.57K
- EV/EBITDA, TTM
- 0.00
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF).
Métricas de valoración
Cronología de eventos
Noticias
4.002-07Business InsiderZomedica Pharmaceuticals (ZOM) Receives a Buy from Noble Financial
5.012-23BenzingaZomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health
- 5.012-19Business Insider
Zomedica Appoints New CFO to Drive Growth
7.510-03BenzingaZomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach
7.510-03SeekingAlphaZomedica expands distribution agreement in Europe with Grovet (NYSE:ZOM)
ZOM FAQ — answered by Alphio AI
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF). It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.